.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Fish and Richardson
Baxter
McKesson
Johnson and Johnson
Farmers Insurance
Daiichi Sankyo
Moodys
Novartis
Boehringer Ingelheim

Generated: July 22, 2017

DrugPatentWatch Database Preview

ROWASA Drug Profile

« Back to Dashboard

Which patents cover Rowasa, and what generic Rowasa alternatives are available?

Rowasa is a drug marketed by Mylan Speciality Lp and Meda Pharms and is included in two NDAs.

The generic ingredient in ROWASA is mesalamine. There are twenty-seven drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the mesalamine profile page.

Summary for Tradename: ROWASA

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list5
Bulk Api Vendors: see list112
Clinical Trials: see list1
Patent Applications: see list6,265
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ROWASA at DailyMed

Pharmacology for Tradename: ROWASA

Ingredient-typeAminosalicylic Acids
Drug ClassAminosalicylate
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Speciality Lp
ROWASA
mesalamine
ENEMA;RECTAL019618-001Dec 24, 1987ABRXYesYes► Subscribe► Subscribe
Meda Pharms
ROWASA
mesalamine
SUPPOSITORY;RECTAL019919-001Dec 18, 1990DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ROWASA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Speciality Lp
ROWASA
mesalamine
ENEMA;RECTAL019618-001Dec 24, 19874,657,900► Subscribe
Mylan Speciality Lp
ROWASA
mesalamine
ENEMA;RECTAL019618-001Dec 24, 1987RE33239► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Cantor Fitzgerald
Farmers Insurance
Argus Health
Queensland Health
Deloitte
McKesson
Daiichi Sankyo
Mallinckrodt
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot